Noninvasive identification and monitoring of cancer mutations by targeted deep sequencing of plasma DNA
- PMID: 22649089
- DOI: 10.1126/scitranslmed.3003726
Noninvasive identification and monitoring of cancer mutations by targeted deep sequencing of plasma DNA
Abstract
Plasma of cancer patients contains cell-free tumor DNA that carries information on tumor mutations and tumor burden. Individual mutations have been probed using allele-specific assays, but sequencing of entire genes to detect cancer mutations in circulating DNA has not been demonstrated. We developed a method for tagged-amplicon deep sequencing (TAm-Seq) and screened 5995 genomic bases for low-frequency mutations. Using this method, we identified cancer mutations present in circulating DNA at allele frequencies as low as 2%, with sensitivity and specificity of >97%. We identified mutations throughout the tumor suppressor gene TP53 in circulating DNA from 46 plasma samples of advanced ovarian cancer patients. We demonstrated use of TAm-Seq to noninvasively identify the origin of metastatic relapse in a patient with multiple primary tumors. In another case, we identified in plasma an EGFR mutation not found in an initial ovarian biopsy. We further used TAm-Seq to monitor tumor dynamics, and tracked 10 concomitant mutations in plasma of a metastatic breast cancer patient over 16 months. This low-cost, high-throughput method could facilitate analysis of circulating DNA as a noninvasive "liquid biopsy" for personalized cancer genomics.
Similar articles
-
Development of a highly sensitive liquid biopsy platform to detect clinically-relevant cancer mutations at low allele fractions in cell-free DNA.PLoS One. 2018 Mar 16;13(3):e0194630. doi: 10.1371/journal.pone.0194630. eCollection 2018. PLoS One. 2018. PMID: 29547634 Free PMC article.
-
Variants with a low allele frequency detected in genomic DNA affect the accuracy of mutation detection in cell-free DNA by next-generation sequencing.Cancer. 2018 Mar 1;124(5):1061-1069. doi: 10.1002/cncr.31152. Epub 2017 Nov 27. Cancer. 2018. PMID: 29178133 Free PMC article.
-
Prospective blinded study of somatic mutation detection in cell-free DNA utilizing a targeted 54-gene next generation sequencing panel in metastatic solid tumor patients.Oncotarget. 2015 Nov 24;6(37):40360-9. doi: 10.18632/oncotarget.5465. Oncotarget. 2015. PMID: 26452027 Free PMC article. Clinical Trial.
-
Potential clinical utility of ultrasensitive circulating tumor DNA detection with CAPP-Seq.Expert Rev Mol Diagn. 2015 Jun;15(6):715-9. doi: 10.1586/14737159.2015.1019476. Epub 2015 Mar 16. Expert Rev Mol Diagn. 2015. PMID: 25773944 Free PMC article. Review.
-
Using circulating cell-free DNA to monitor personalized cancer therapy.Crit Rev Clin Lab Sci. 2017 May;54(3):205-218. doi: 10.1080/10408363.2017.1299683. Epub 2017 Apr 10. Crit Rev Clin Lab Sci. 2017. PMID: 28393575 Review.
Cited by
-
Ovarian Cancer Diagnosis and Prognosis Based on Cell-Free DNA Methylation.Cancer Control. 2024 Jan-Dec;31:10732748241255548. doi: 10.1177/10732748241255548. Cancer Control. 2024. PMID: 38764160 Free PMC article. Review.
-
Circulating tumor DNA and its role in detection, prognosis and therapeutics of hepatocellular carcinoma.Chin J Cancer Res. 2024 Apr 30;36(2):195-214. doi: 10.21147/j.issn.1000-9604.2024.02.07. Chin J Cancer Res. 2024. PMID: 38751441 Free PMC article.
-
Technical Advances in Circulating Cell-Free DNA Detection and Analysis for Personalized Medicine in Patients' Care.Biomolecules. 2024 Apr 19;14(4):498. doi: 10.3390/biom14040498. Biomolecules. 2024. PMID: 38672514 Free PMC article. Review.
-
Genomic spectrum of actionable alterations in serial cell free DNA (cfDNA) analysis of patients with metastatic breast cancer.NPJ Breast Cancer. 2024 Apr 11;10(1):27. doi: 10.1038/s41523-024-00633-7. NPJ Breast Cancer. 2024. PMID: 38605020 Free PMC article.
-
A Quest for Survival: A Review of the Early Biomarkers of Pancreatic Cancer and the Most Effective Approaches at Present.Biomolecules. 2024 Mar 19;14(3):364. doi: 10.3390/biom14030364. Biomolecules. 2024. PMID: 38540782 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous